Sign in

Global Antibiotic R&D Partnership (GARDP)

@gardp.bsky.social
487 followers 81 following 599 posts

Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR). gardp.org/this-is-big

PostsRepliesMedia
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 29/09/2026
🤝 GARDP and @dndi.org are pleased to announce support from the Foundation for the Adaptation of International Geneva to strengthen collaboration, share capabilities and resources, and help both focus more on developing and ensuring access to treatments for NTDs and drug-resistant infections.
111
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 28/09/2026
🌎 For the first time, GARDP is participating in the PAHO Directing Council, joining health authorities from across the Americas to discuss shared public health priorities. 💊Our work with PAHO is strengthening AMR surveillance, research and antibiotic access. 🎥See the work taking shape in LatAm.
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 22/09/2026
🚀 #GAMRIC2026 kicks off in Lisbon For the next three days, people working across #AMR are coming together to talk about what is changing in the science, where the gaps remain, and what it will take to develop better tools against AMR. Come meet the team!
010
Reposted by Global Antibiotic R&D Partnership (GARDP)
ESCMID @escmid.bsky.social · 21/09/2026
#GAMRIC2026 starts tomorrow! We are excited to welcome you to Lisbon, Portugal and hope you enjoy the innovative programme and opportunities to connect. Follow along over the next days as we cover highlights from the conference. LifeArc CARB-X Global Antibiotic R&D Partnership (GARDP)
151
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 18/09/2026
#ACC2027 registration & abstract submissions are open! Join the free, virtual conference on #AMR jointly organised by @bsacandjac.bsky.social and GARDP with @eupohamr.bsky.social as collaborating organization for 2027. 🔗Register: tinyurl.com/mr2bftrv 👉Submit an abstract: tinyurl.com/bddwc49x
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 17/09/2026
In Brazil, GARDP & Fiocruz are working with hospitals & labs to understand resistance profiles for the responsible use of Reserve antibiotics, including susceptibility to cefiderocol. Microbiologists recently trained at Fiocruz’s LABSUR for training in antimicrobial susceptibility testing.
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 16/09/2026
1 WEEK TO GO | #GAMRIC2026 🗓️22–24 Sept 2026 📍Lisbon, Portugal In one week, researchers, academics and industry experts from around the world will meet at the 2nd Global AMR Innovators Conference (GAMRIC) 2026 to explore innovations addressing #AMR. 🔗Register now: www.gamric.org/registration...
120
Reposted by Global Antibiotic R&D Partnership (GARDP)
Medicines for Malaria Venture (MMV) @mmv.org · 14/09/2026
Does your organization have insights into how AI can improve clinical trial design and documentation? MMV, @dndi.org and @gardp.bsky.social are mapping AI solutions for clinical study design, operations and medical writing. Submission deadline: 7 October Learn more: bit.ly/3UMwkeW
022
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 15/09/2026
#FungalAwarenessWeek2026 | 2 days to go! Join #REVIVE on 17 Sept for our webinar exploring newer azoles, extended dosing, long half-life echinocandins and novel antifungals, with a live Q&A. attendee.gotowebinar.com/register/754...
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 14/09/2026
Newly published GARDP-sponsored research offers encouraging evidence for expanding treatment options for newborns with sepsis. 🔗 pubmed.ncbi.nlm.nih.gov/42705380/ #AMR #GARDP
pubmed.ncbi.nlm.nih.gov
In vitro activity of flomoxef, fosfomycin and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens - PubMed
The results confirm the potential of these combinations as carbapenem-sparing treatments and provide additional evidence to support the evaluation of these combinations in the neonatal sepsis trial that is sponsored by GARDP (ISRCTN48721236).
101
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 13/09/2026
On #WorldSepsisDay, we’re reminded that treating sepsis depends on having antibiotics that work. As resistance grows, those options are shrinking. “Invest in Sepsis – Save Lives” means investing in the treatments we need to stay ahead. #AMRIsBig #OurResponseIsBigger
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 11/09/2026
In Germany, earlier diagnosis helps patients receive treatment for sepsis sooner, but AMR is making infections harder to treat. Peter Beyer writes in Tagesspiegel Background on why sepsis investment must include new antibiotics: tinyurl.com/3pt7tama #WorldSepsisDay #AMRIsBig #OurResponseIsBigger
gardp.org
Sepsis: A race against time – and against resistance. – GARDP
11 September 2026 Published in the Tagesspiegel Background By Peter Beyer, Deputy Executive Director, the Global Antibiotic Research & Development Partnersh
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 11/09/2026
Personalized phage therapy has strong biological promise. But making it part of routine #AMR care will depend on stronger infrastructure. A new #REVIVE viewpoint explores what it will take to scale. 🔗https://tinyurl.com/53y2pf54
131
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 09/09/2026
💻 Register for #REVIVE’s 29 Sept webinar on clinical trial evidence shaping antibiotic use. ⏰29 Sept | 13:30 - 15:00 CEST attendee.gotowebinar.com/register/261... @jesusrbano.bsky.social I @clarityinitiative.bsky.social
121
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 08/09/2026
STARTING 🔜 Join the #WorldSepsisDay webinar exploring how neonatal antimicrobial stewardship can improve antibiotic use today and help protect treatment options for tomorrow. GARDP’s Justin Green will be joining the expert discussion.
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 08/09/2026
New in @thelancet.com: the PediCAP trial brings important evidence on treating severe community-acquired pneumonia in young children in African hospitals. The trial used a novel design to examine IV-to-oral antibiotic step-down, antibiotic choice and more. 🔗 www.thelancet.com/journals/lan...
thelancet.com
Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial
For sub-Saharan African children hospitalised with severe CAP without complicating factors, a strategy of stepping down upon clinical improvement to oral amoxicillin after initial intravenous antibiot...
133
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 07/09/2026
Journalist Md Zahid Hossain Khan investigates AMR in Bangladesh’s ICUs and NICUs in a new Daily Sun feature. The story is part of GARDP’s first-ever #WithoutBordersMediaFellowship, supporting in-depth AMR reporting across South Asia. 🔗Read the full article here: www.daily-sun.com/health/89640...
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/09/2026
What does a new antibiotic have to do with sexual health? More than you might think. As gonorrhoea becomes harder to treat, impact can reach reproductive health, pregnancy and newborns. That makes antibiotic innovation part of sexual health. 🦠 #AMRIsBIG #OurResponseIsBIGGER
230
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 02/09/2026
📅 Save the date: 9–11 Feb 2027 The #ACC2027 is a free, open-access virtual conference, jointly organised by @bsacandjac.bsky.social and GARDP within the framework of the @eupohamr.bsky.social. More info coming soon! 🌐Explore the website: acc-conference.com
023
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 01/09/2026
Developing a new antibiotic is only half the race. 🌍 But it's equally important that treatments reach the countries and communities with the greatest need, without unnecessary delays. 💊At GARDP, we believe antibiotic innovation and access must go hand in hand in the fight against #AMR.
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 31/08/2026
Learn how public-private partnerships help facilitate drug development, advance research, provide financing and share risks in this REVIVE Encyclopaedia video featuring Clara Maure from GARDP. 🎥 revive.gardp.org/resource/pub... #AMR #REVIVE
revive.gardp.org
Public-private partnership (PPP)
A public-private partnership (PPP) is defined as a collaborative agreement between a public sector entity and a private party to manage, advance, or finance a project with public value. PPPs are typ...
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 28/08/2026
What would happen if antibiotics stopped working? In a recent interview with GARDP, Dr. Norio Ohmagari discusses the growing threat of AMR, the challenges facing antibiotic development and the importance of global collaboration. 🔗Read the full interview: gardp.org/healthcare-i...
gardp.org
“Healthcare itself may cease to function” – GARDP
Dr. Norio Ohmagari on Japan’s AMR crisis and global challenges Dr. Norio Ohmagari is an infectious disease specialist and medical doctor. He serves as Director
021
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 27/08/2026
🎙️Join us for AMR Discussions Webinar - Breaking the resistance: Empowering the next generation of antimicrobial researchers. 📅3 Sept | 🕒15:00–16:00 CEST Explore the shortage of specialised antimicrobial researchers & solutions to attract & retain talent. 👉 register.gotowebinar.com/register/298...
030
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 26/08/2026
👶 A bigger response means putting children first Too often, children wait for evidence to guide antibiotic treatment. Together with @pentafoundation.bsky.social, we're helping close the evidence gap for children and ensure they are part of antibiotic development from the start.
220
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 26/08/2026
swissinfo.ch takes a closer look at the strategic collaboration between @dndi.org, @mmv.org and GARDP as the global health landscape changes. 🔗Read here: www.swissinfo.ch/eng/new-trea...
110
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 25/08/2026
On #WorldSepsisDay, join experts exploring how antimicrobial stewardship can strengthen neonatal care, improve antibiotic use and help address AMR. GARDP’s Justin Green will join the discussion. 📅 8 Sept | 3pm EAT | 1pm WAT | 1pm BST | 8am EDT 🔗 newborntoolkit.org/webinars/wor...
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 25/08/2026
GARDP & the South African Medical Research Council recently convened experts in Cape Town to help shape GARDP's Strategic Plan 2027-31. The discussion focused on South African priorities for developing & improving access to much-needed antibiotic treatments in the region. @samrcza.bsky.social
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 23/08/2026
⏳ One month to go until #GAMRIC2026! Join the global AMR community in Lisbon for three days of discussions on breakthroughs in therapeutics, diagnostics, vaccines and preventatives addressing AMR. 📍 Lisbon, Portugal 📅 22–24 September 🔗 www.gamric.org
141
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 21/08/2026
🎙️ Join our AMR Discussions webinar on 3 Sept (14:30-15:30 CEST) As expert researchers leave or retire, how can we attract and retain the talent needed to secure the future of antibiotic development? 🔗Register: attendee.gotowebinar.com/register/298...
163
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 19/08/2026
🌍 Since 2018, REVIVE has helped bring together researchers from clinical, industry and academic settings to share expert #AMR knowledge. 📚 Through a growing library of free resources, REVIVE supports early-stage antimicrobial researchers. 🌐Explore everything #REVIVE has to offer: revive.gardp.org
041
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 18/08/2026
📝 New in STAT: What if the global antibiotic crisis isn’t just about overuse, but underuse too? New research in @thelancet.com points to overuse in some parts of the world and underuse in others. Peter Beyer explores what this means for access and stewardship. 🔗 www.statnews.com/2026/08/18/a...
141
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 17/08/2026
📖Have you read GARDP's Annual Report 2025 yet? Read how GARDP is turning vision into reality, and why the journey is far from over. 🔗Read the report: gardp.org/annual-repor... #AnnualReport #AMR #AntimicrobialResistance #GlobalHealth #GARDP
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 14/08/2026
#FungalAwarenessWeek2026 is almost here! Join REVIVE on 17 September for a webinar exploring recent advances to overcome pharmacokinetic & pharmacodynamic challenges in antifungal therapy. Hear from leading experts & take part in a live Q&A. 📅 Register: register.gotowebinar.com/register/754...
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 12/08/2026
🏆 NUZOLVENCE® (zoliflodacin) has been nominated for the 2026 Prix Galien USA Award for Best Pharmaceutical Product This first new antibiotic developed solely for gonorrhoea in decades is developed in a public-private partnership between GARDP and Innoviva Specialty Therapeutics tinyurl.com/jja4paej
001
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 11/08/2026
A new Letter to the Editor in the Journal of Translational Medicine welcomes the draft ICH E21 guideline and calls for action to close evidence gaps for pregnant and breastfeeding women. Congrats to Tammy Meyers, the Collaborative Group and @dndi.org. 📖Read: link.springer.com/article/10.1...
link.springer.com
ICH E21: from landmark guidance to specific action for maternal and child health - Journal of Translational Medicine
Journal of Translational Medicine -
110
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 10/08/2026
🦠 Last year, our campaign #ThisIsBig highlighted the scale of antimicrobial resistance. This year, we're focusing on what it takes to change its trajectory. 💥 AMR is BIG. Our response is BIGGER. Follow us as we spotlight our partnerships and how innovations can drive a bigger response to AMR.
100
Reposted by Global Antibiotic R&D Partnership (GARDP)
LifeArc @lifearc.bsky.social · 06/08/2026
#GAMRIC2026 is next month! If you haven't registered yet, get inspired by what our Chair of Global Health, Kelly Chibale, had to say about last year's edition. Register now: gamric.org #GlobalHealth #AMR
011
Reposted by Global Antibiotic R&D Partnership (GARDP)
ESCMID @escmid.bsky.social · 06/08/2026
Valeria Gigante (WHO) reflects on her experience at the first GAMRIC including the importance of the conference and why it stands out including its focus on R&D and collaboration. Watch here: youtu.be/dkcKeTfagXk #GAMRIC2026 LifeArc CARB-X Global Antibiotic R&D Partnership (GARDP)
021
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 07/08/2026
New antibiotics may reach patients faster, but approval is only the beginning. The latest REVIVE Antimicrobial Viewpoint by Ursula Theuretzbacher explores why coordinated, adaptive post-approval evidence generation is essential. 🔗 tinyurl.com/yyhuvjff Developed in collab with @cmicomms.bsky.social
153
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 06/08/2026
📝💊 A new SECURE report highlights a critical challenge in the fight against #AMR: access to essential antibiotics remains uneven across the WHO African Region. 📖 Read the report: www.who.int/publications... @who.int
221
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 05/08/2026
A new RIVM risk assessment identifies #AMR as the leading international public health risk for the Netherlands over the coming decade & recognizes that tackling AMR requires stronger preparedness, international collaboration & continued investment in antibiotic R&D. 📖 www.rivm.nl/publicaties/...
rivm.nl
Global risk assessment of public health in the Netherlands. Better prepared for the future | RIVM
300
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 03/08/2026
GARDP has signed a memorandum of understanding with ILDONG Pharmaceutical to explore how to strengthen future supply and access pathways for flomoxef, an antibiotic being studied for neonatal sepsis.
100
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 01/08/2026
We're hiring! GARDP is looking for a Consultant – Medical Affairs & Clinical Coordination in Delhi to support access to a priority antibacterial treatment through clinical evidence, regulatory engagement and expert collaboration. 📍 Delhi | 📅 6-month consultancy (extendable) 📩 aroy@gardp.org
010
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 31/07/2026
For decades, the global pipeline for developing and delivering new antibiotics has worked in reverse. In his latest @telegraph.co.uk op-ed, Peter Beyer explains how Thailand's fast-track approval of zoliflodacin could help turn that model on its head. 🔗 www.telegraph.co.uk/global-healt...
telegraph.co.uk
New drug for super-gonorrhoea points to better antibiotic development
It is possible to break the cycle that has left much of the world waiting years for new antibiotics
162
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 29/07/2026
In Luska, Zambia, alongside #RAAC2026, GARDP brought together government representatives, researchers, clinicians, advocates and AMR experts to help inform its 2027–2031 strategy. The most effective solutions are grounded in regional expertise and shaped by those closest to the challenge.
100
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 27/07/2026
🚨 This is BIG! The Thai FDA has approved NUZOLVENCE® (zoliflodacin), a first-in-class oral antibiotic for the treatment of uncomplicated urogenital gonorrhoea, just 6 months after its initial approval by the US FDA. 🔗 gardp.org/thai-fda-app...
122
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 24/07/2026
✨ We've got a fresh new look! The new GARDP website is live — our biggest digital evolution since we were founded. Explore our programmes, projects, research, stories and more through a faster, more intuitive experience. 🌐 gardp.org Bacteria are evolving. So must we. #AMR #GlobalHealth
000
Reposted by Global Antibiotic R&D Partnership (GARDP)
International Society for Infectious Diseases (ISID) @isid.org · 15/07/2026
Experience #ICID2026 in Madrid this November! Explore a multidisciplinary programme covering AI, genomic surveillance, One Health, AMR, research equity, and more. 🔗 Scientific Programme: ow.ly/e9pi50ZnE99 ⏰ Early Bird ends 30 July: ow.ly/jYI050ZnE96 #ISID #GlobalHealth
011
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 22/07/2026
⚠️ People across Latin America and the Caribbean face delays in accessing Reserve antibiotics, even after these medicines have been approved elsewhere. Our new review explores why, and highlights opportunities to improve access through coordinated regional action. 🔗 Read: tinyurl.com/4xjm5ay9
221
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 20/07/2026
A major milestone for GARDP's #NeoSep1 trial 🎉 The first baby has now been enrolled in Vietnam, continuing the expansion of this landmark neonatal sepsis trial from Africa into Asia.
112